awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38222680-AB433BC4-8B90-44A2-ACBA-2751A882BF0E
Q38222680-AB433BC4-8B90-44A2-ACBA-2751A882BF0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38222680-AB433BC4-8B90-44A2-ACBA-2751A882BF0E
Siltuximab: first global approval.
P2860
Q38222680-AB433BC4-8B90-44A2-ACBA-2751A882BF0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38222680-AB433BC4-8B90-44A2-ACBA-2751A882BF0E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a5c9deb4166da86d77c7d75c4fbf15ee26af77a
P2860
Targeted inhibition of interleukin-6 with CNTO 328 sensitizes pre-clinical models of multiple myeloma to dexamethasone-mediated cell death.